Artículos

2012

doi: 10.1182/blood-2012-02-411215

Apolymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera

Hernández-Boluda JC, Pereira A, Cervantes F, Alvarez-Larrán A, Collado M, Such E, Arilla MJ, Boqué C, Xicoy B, Maffioli M, Bellosillo B, Marugán I, Amat P, Besses C, Guillem V.

2012

doi: 10.1016/j.leukres.2011.10.015

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia

Ottone T, Cicconi L, Hasan SK, Lavorgna S, Divona M, Voso MT, Montefusco E, Melillo L, Barragán E, Platzbecker U, Giannì L, Hubmann M, Pagoni M, Amadori S, Lo-Coco F

2012

doi: 10.1016/j.medcli.2011.11.011

Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria

Sanz MA, Vicente V, Fernández A, López MF, Grande C, Jarque I, Martínez R, Mingot ME, Monteagudo E, Ribera JM, Valcarcel D

2012

doi: 10.1200/JCO.2011.35.6394

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

chanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D.

2012

doi: 10.1007/s10689-011-9481-7

Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population

de Juan Jiménez I, Esteban Cardeñosa E, Palanca Suela S, Barragán González E, Aznar Carretero I, Munárriz Gandía B, Santaballa Bertran A, Torregrosa Maicas MD, Guillén Ponce C, Sánchez Heras AB, Bayón Lara A, Fuster Lluch O, Bolufer Gilabert P

2014

doi: 10.1016/j.leukres.2011.06.011

Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia

Guillem V, Amat P, Cervantes F, Alvarez-Larrán A, Cervera J, Maffioli M, Bellosillo B, Collado M, Marugán I, Martínez-Ruiz F, Hernández-Boluda JC.

2012

doi: 10.1038/ni.2255

The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials

Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, Bouriez-Jones T, Lutteropp M, Woll PS, Loughran SJ, Mead AJ, Hultquist A, Brown J, Mizukami T, Matsuoka S, Ferry H, Anderson K, Duarte S, Atkinson D, Soneji S, Domanski A, Farley A, Sanjuan-Pla A, Carella C, Patient R, de Bruijn M, Enver T, Nerlov C, Blackburn C, Godin I, Jacobsen SE

2012

doi: 10.1002/cncr.26279.

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome

Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry.

2012

doi: 10.1007/s00277-011-1234-z

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.

Fuster O, Barragán E, Bolufer P, Such E, Valencia A, Ibáñez M, Dolz S, de Juan I, Jiménez A, Gómez MT, Buño I, Martínez J, Cervera J, Montesinos P, Moscardó F, Sanz MÁ.

2012

doi: 10.1007/s00277-011-1331-z

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.

Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA.

2012

2012

doi: 10.1038/emboj.2011.390

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors

Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C

2020

doi: 10.1182/blood-2011-07-370460

High-risk Cytogenetics and Persistent Minimal Residual Disease by Multiparameter Flow Cytometry Predict Unsustained Complete Response After Autologous Stem Cell Transplantation in Multiple Myeloma

Montalbán MÁ, Martínez-López J, Mateos MV, Cibeira MT, Cordón L, Oriol A, Terol MJ, Echeveste MA, de Paz R, de Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Sureda A, Gorosquieta A, Alegre A, Martin A, Hernández MT, Lahuerta JJ, Bladé J, San Miguel JF; PETHEMA/GEM (Programa para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma)

2012

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Grau S, la Cámara de R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA

2012

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination

Rojas R, Molina JR, Jarque I, Montes C, Serrano J, Sanz J, Besalduch J, Carreras E, Tomas JF, Madero L, Rubio D, Conde E, Sanz MA, Torres A

2012

Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient

Cervelló I, Gil-Sanchis C, Mas A, Faus A, Sanz J, Moscardo F, Higueras G, Sanz MA, Pellicer A, Simón C

2012

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

Valcarcel D, Montesinos P, Sánchez-Ortega I, Brunet S, Esteve J, Martínez-Cuadrón D, Ribera JM, Tormo M, Bueno J, Duarte R, Llorente A, Torres JP, Guardia R, Sanz MA, Sierra AJ, CETLAM Group

2012

doi: 10.1016/j.leukres.2011.10.029

Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML)

Such E, Cervera J, Ibáñez M, Gómez-Seguí I, Luna I, López-Pavía M, Mallo M, Collado R, Vicente A, Hernández-Boluda JC, Luño E, Andreu R, Sanz GF, Sanz MA

2012

Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients

Montesinos P, Gascón A, Martínez-Cuadrón D, Senent M-L, Cordón L, Sanz J, Sempere A, López-Pavía M, Rodríguez-Veiga R, Hurtado MJ, Gomis F, Martín G, Lorenzo I, Palau J, Planelles MD, Larrea L, Carpio N, Pérez-Sirvent M, Sanz MA, Sanz GF

2012

The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

Rego EM, Kim HT, Ruiz-Argüelles GJ, Uriarte MDR, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille M de L, Chiattone C, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan H, Garcés-Eisele J, Gallagher R, Niemeyer CM, Löwenberg B, Ribeiro R, LoCoco F, Sanz MA

2012

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

Weitz I, Sanz MA, Henry D, Schipperus M, Godeau B, Northridge K, Gleeson M, Danese M, Deuson R

2012

Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group

Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Ades L

2012

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

Spyridonidis A, Labopin M, Schmid C, Volin L, Yakoub-Agha I, Stadler M, Milpied N, Socie G, Browne P, Lenhoff S, Sanz MA, Aljurf M, Mohty M, Rocha V, Immunotherapy Subcommittee of Acute Leukemia Working Party

2012

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

Sanz J, Boluda JCH, Martín C, González M, Ferrá C, Serrano D, de Heredia CD, Barrenetxea C, Martinez AM, Solano C, Sanz MA, Sanz GF, Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH)

2012

Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients

Luna I, Such E, Cervera J, Barragán E, Jiménez-Velasco A, Dolz S, Ibáñez M, Gómez-Seguí I, López-Pavía M, Llop M, Fuster Ó, Oltra S, Moscardó F, Martínez-Cuadrón D, Senent ML, Gascón A, Montesinos P, Martín G, Bolufer P, Sanz MA

2012

Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting

Ibáñez M, Such E, Cervera J, Luna I, Gómez-Seguí I, López-Pavía M, Dolz S, Barragán E, Fuster Ó, Llop M, Rodríguez-Veiga R, Avaria A, Oltra S, Senent ML, Moscardó F, Montesinos P, Martínez-Cuadrón D, Martín G, Sanz MA

2012

Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia

Gaur GC, Ramadan SM, Cicconi L, Noguera NI, Luna I, Such E, Lavorgna S, Di Giandomenico J, Sanz MA, Lo-Coco F

2012

doi: 10.1016/j.bbmt.2011.05.021

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Bosch-Vizcaya, Anna; Perez-Garcia, Arianne; Brunet, Salut; Solano, Carlos; Buno, Ismael; Guillem, Vicent; Martinez-Laperche, Carolina; Sanz, Guillermo; Barrenetxea, Cristina; Martinez, Carmen; Tuset, Esperanza; Lloveras, Natalia; Coll, Rosa; Guardia, Ramon; Gonzalez, Yolanda; Roncero, Josep M.; Bustins, Anna; Gardella, Santiago; Fernandez, Cristalina; Buch, Joan; Gallardo, David

2012

doi: 10.1007/s00277-012-1538-7

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

Santamaria, Carlos; Ramos, Fernando; Puig, Noemi; Barragan, Eva; de Paz, Raquel; Pedro, Carme; Insunza, Andres; Tormo, Mar; del Canizo, Consuelo; Diez-Campelo, Maria; Xicoy, Blanca; Salido, Eduardo; Sanchez del Real, Javier; Hernandez, Montserrat; Chillon, Carmen; Sanz, Guillermo F.; Garcia-Sanz, Ramon; San Miguel, Jesus F.; Gonzalez, Marcos

2012

doi: 10.1016/j.leukres.2011.10.025

The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome

Cordoba, I.; Gonzalez-Porras, J. R.; Such, E.; Nomdedeu, B.; Luno, E.; de Paz, R.; Carbonell, F.; Vallespi, T.; Ardanaz, M.; Ramos, F.; Marco, V.; Bonanad, S.; Sanchez-Barba, M.; Costa, D.; Bernal, T.; Sanz, G. F.; Canizo, M. C.

2012

doi: 10.1111/bjh.12035

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

Saumell, Silvia; Florensa, Lourdes; Luno, Elisa; Sanzo, Carmen; Canizo, Consuelo; Hernandez, Jesus M.; Cervera, Jose; Gallart, Miguel A.; Carbonell, Felix; Collado, Rosa; Arenillas, Leonor; Pedro, Carme; Bargay, Joan; Nomdedeu, Benet; Xicoy, Blanca; Vallespi, Teresa; Raya, Jose M.; Belloch, Luis; Sanz, Guillermo F.; Sole, Francesc

2012

doi: 10.1182/blood-2012-03-420489

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Greenberg, Peter L.; Tuechler, Heinz; Schanz, Julie; Sanz, Guillermo; Garcia-Manero, Guillermo; Sole, Francesc; Bennett, John M.; Bowen, David; Fenaux, Pierre; Dreyfus, Francois; Kantarjian, Hagop; Kuendgen, Andrea; Levis, Alessandro; Malcovati, Luca; Cazzola, Mario; Cermak, Jaroslav; Fonatsch, Christa; Le Beau, Michelle M.; Slovak, Marilyn L.; Krieger, Otto; Luebbert, Michael; Maciejewski, Jaroslaw; Magalhaes, Silvia M. M.; Miyazaki, Yasushi; Pfeilstoecker, Michael; Sekeres, Mikkael; Sperr, Wolfgang R.; Stauder, Reinhard; Tauro, Sudhir; Valent, Peter; Vallespi, Teresa; van de Loosdrecht, Arjan A.; Germing, Ulrich; Haase, Detlef

2011

doi: 10.1016/j.bbmt.2011.04.009

Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients

Barba P, Piñana JL, Fernández-Avilés F, Perez-Simón JA, Martino R, López-Guerrero E, Valcárcel D, Rovira M, Novelli S, Campos-Varela I, López-Anglada L, Vidal X, López Corral L, Carreras E, Sierra J

2011

doi: 10.1016/j.radmeas.2011.05.009

Assessment in vitro of radioprotective efficacy of curcumin and resveratrol

Natividad Sebastià, Alegria Montoro, Amparo Montoro, Miguel Almonacid, Juan Ignacio Villaescusa, José Cervera ,Esperanza Such Ma Angeles Silla, Jose Miguel Soriano

2011

Romiplostim: A new chance in ITP | [Romiplostim: Una nueva oportunidad en PTI]

Jordán De Luna, M.C., Romá Sánchez, E., Jarque Ramos, I., Poveda Andrés, J.L

2011

doi: 10.1038/bmt.2010.177

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: Longitudinal analysis from 1994 to 2008 at a single institution

Martino R, Kerguelen A, Valcárcel D, Sureda A, Fachini L, Piñana JL, Briones J, Delgado J, Brunet S, Sierra J

2011

doi: 10.1007/s12185-011-0825-8

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: A case and control study

Remacha AF, Souto JC, Piñana JL, Sardà MP, Queraltó JM, Martí-Fabregas J, García-Moll X, Férnandez C, Rodriguez A, Cuesta J

2011

doi: 10.1586/ehm.10.77

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, Solano C, de la Cámara R, Rosell AI, Varela R, García MD, González-Barca E, López J, Pérez E, Ferrer S, Casado LF, Vázquez L, Villalón L, García-Marco JA

2011

doi: 10.1177/2040620710396752

Long-Term Results of Fludarabine/Melphalan as a Reduced-Intensity Conditioning Regimen in Mantle Cell Lymphoma: The GELTAMO Experience

Cruz JG, Martino R, Balsalobre P, Heras I, Piñana JL, Serrano D, de la Serna J, Tomás JF, Díez-Martíin JL, Caballero D

2011

doi: 10.3851/IMP1858

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A

2011

Eculizumab in paroxysmal nocturnal haemoglobinuria

Escudero-Jimenez, A., Esteban-Mensua, M.J., Lopez, E., Jarque-Ramos, I., Borrell-Garcia, C., Poveda-Andres, J.L.

2011

The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature

Montesinos P, Sanz MA

2011

The European LeukemiaNet: achievements and perspectives

Hehlmann R, Grimwade D, Simonsson B, Apperley J, Baccarani M, Barbui T, Barosi G, Bassan R, Béné MC, Berger U, Büchner T, Burnett A, Cross NCP, de Witte TJM, Döhner H, Dombret H, Einsele H, Engelich G, Foà R, Fonatsch C, Gökbuget N, Gluckman E, Gratwohl A, Guilhot F, Haferlach C, Haferlach T, Hallek M, Hasford J, Hochhaus A, Hoelzer D, Kiladjian J-J, Labar B, Ljungman P, Mansmann U, Niederwieser D, Ossenkoppele G, Ribera JM, Rieder H, Serve H, Schrotz-King P, Sanz MA, Saussele S, European LeukemiaNet

2011

Treatment of multiple myeloma in the elderly: realities and hopes

la Rubia de J, Sanz MA

2011

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mallo M, Cervera J, Schanz J, Such E, García-Manero G, Luño E, Steidl C, Espinet B, Vallespí T, Germing U, Blum S, Ohyashiki K, Grau J, Pfeilstöcker M, Hernández JM, Noesslinger T, Giagounidis A, Aul C, Calasanz MJ, Martín ML, Valent P, Collado R, Haferlach C, Fonatsch C, Lübbert M, Stauder R, Hildebrandt B, Krieger O, Pedro C, Arenillas L, Sanz MA, Valencia A, Florensa L, Sanz GF, Haase D, Solé F

2011

Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)

Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ

2011

A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia

Such E, Cervera J, Valencia A, Barragán E, Ibáñez M, Luna I, Fuster Ó, Perez-Sirvent ML, Senent L, Sempere A, Martínez J, Martín-Aragonés G, Sanz MA

2011

Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4?7, 2010, Orlando, Florida

Tallman MS, Lo-Coco F, Kwaan HC, Sanz MA, Gore SD

2011

Modern approaches to treating acute promyelocytic leukemia

Sanz MA, Lo-Coco F

2011

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, la Serna de J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Löwenberg B, Sanz MA, PETHEMA, HOVON Groups

2011

Update on bacteraemia in oncology and hematology

Fortún J, Sanz MA, Madero L, López J, la Torre de J, Jarque I, Vallejo C

2011

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes

Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F

2011

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD

2011

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

Ammatuna E, Montesinos P, Hasan SK, Ramadan SM, Esteve J, Hubmann M, Pagoni M, Grimwade D, Sanz MA, Lo-Coco F

2011

Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts

Valencia A, Cervera J, Such E, Ibáñez M, Gómez I, Luna I, Senent L, Oltra S, Sanz MA, Sanz GF

2011

[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]

Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert-Lleti M, la Cámara de R, Borges M, Cervera C, Garnacho J, Lassaleta Á, Lumbreras C, Sanz MA, Ramos JT, Torre-Cisneros J, Aguado JM, Cuenca-Estrella M, Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)

2011

Whole-genome sequencing and acute promyelocytic leukemia

Lo-Coco F, Sanz MA

2011

Central nervous system involvement at first relapse in patients with acute myeloid leukemia

Martínez-Cuadrón D, Montesinos P, Pérez-Sirvent M, Avaria A, Cordón L, Rodríguez-Veiga R, Martín G, Sanz J, Martínez J, Sanz MA

2011

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Michel M, Boekhorst te PAW, Janssens A, Pabinger-Fasching I, Sanz MA, Nie K, Kreuzbauer G

2011

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Barragán E, Montesinos P, Camos M, González M, Calasanz MJ, Román-Gómez J, Gómez-Casares MT, Ayala R, López J, Fuster Ó, Colomer D, Chillón C, Larrayoz MJ, Sánchez-Godoy P, González-Campos J, Manso F, Amador ML, Vellenga E, Löwenberg B, Sanz MA, PETHEMA, HOVON Groups

2011

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

Vázquez I, Maicas M, Cervera J, Agirre X, Marin-Béjar O, Marcotegui N, Vicente C, Lahortiga I, Gomez-Benito M, Carranza C, Valencia A, Brunet S, Lumbreras E, Prosper F, Gómez-Casares MT, Hernández-Rivas JM, Calasanz MJ, Sanz MA, Sierra J, Odero MD

2011

CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Such E, Cervera J, Terpos E, Bagán JV, Avaria A, Gómez I, Margaix M, Ibáñez M, Luna I, Cordón L, Roig M, Sanz MA, Dimopoulos MA, la Rubia de J

2011

doi: 10.1182/blood-2011-01-330126

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Fenaux, Pierre; Giagounidis, Aristoteles; Selleslag, Dominik; Beyne-Rauzy, Odile; Mufti, Ghulam; Mittelman, Moshe; Muus, Petra; Boekhorst, Peter Te; Sanz, Guillermo; del Canizo, Consuelo; Guerci-Bresler, Agnes; Nilsson, Lars; Platzbecker, Uwe; Luebbert, Michael; Quesnel, Bruno; Cazzola, Mario; Ganser, Arnold; Bowen, David; Schlegelberger, Brigitte; Aul, Carlo; Knight, Robert; Francis, John; Fu, Tommy; Hellstrom-Lindberg, Eva

2011

doi: 10.1016/j.leukres.2011.01.003

Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome

Mallo, Mar; Luno, Elisa; Sanzo, Carmen; Cervera, Jose; Haase, Detlef; Schanze, Julie; Garcia-Manero, Guillermo; del Canizo, Consuelo; Sanz, Guillermo F.; Sole, Francesc

2011

doi: 10.1002/cncr.25774

Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic Syndromes

Silverman, Lewis R.; Fenaux, Pierre; Mufti, Ghulam J.; Santini, Valeria; Hellstrom-Lindberg, Eva; Gattermann, Norbert; Sanz, Guillermo; List, Alan F.; Gore, Steven D.; Seymour, John F.

2011

doi: 10.3324/haematol.2010.030957

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Such, Esperanza; Cervera, Jose; Costa, Dolors; Sole, Francesc; Vallespi, Teresa; Luno, Elisa; Collado, Rosa; Calasanz, Maria J.; Hernandez-Rivas, Jesus M.; Cigudosa, Juan C.; Nomdedeu, Benet; Mallo, Mar; Carbonell, Felix; Bueno, Javier; Ardanaz, Maria T.; Ramos, Fernando; Tormo, Mar; Sancho-Tello, Reyes; del Canizo, Consuelo; Gomez, Valle; Marco, Victor; Xicoy, Blanca; Bonanad, Santiago; Pedro, Carmen; Bernal, Teresa; Sanz, Guillermo F.

2011

doi: 10.1016/S1470-2045(11)70260-1

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis

Eapen, Mary; Klein, John P.; Sanz, Guillermo F.; Spellman, Stephen; Ruggeri, Annalisa; Anasetti, Claudio; Brown, Maria; Champlin, Richard E.; Garcia-Lopez, Joan; Hattersely, Gareth; Koegler, Gesine; Laughlin, Mary J.; Michel, Gerard; Nabhan, Samir K.; Smith, Franklin O.; Horowitz, Mary M.; Gluckman, Eliane; Rocha, Vanderson

2011

doi: 10.1016/j.bbmt.2010.06.011

Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

de Latour, Regis Peffault; Purtill, Duncan; Ruggeri, Annalisa; Sanz, Guillermo; Michel, Gerard; Gandemer, Virginie; Maury, Sebastien; Kurtzberg, Joanne; Bonfim, Carmen; Aljurf, Mahmoud; Gluckman, Eliane; Socie, Gerard; Passweg, Jakob; Rocha, Vanderson

2011

doi: 10.1002/cncr.26173

Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

Ramon Gonzalez-Porras, Jose; Cordoba, Iris; Such, Esperanza; Nomdedeu, Benet; Vallespi, Teresa; Carbonell, Felix; Luno, Elisa; Ardanaz, Maite; Ramos, Fernando; Pedro, Carme; Gomez, Valle; de Paz, Raquel; Sanchez-Barba, Mercedes; Sanz, Guillermo F.; del Canizo, Consuelo

2011

doi: 10.1016/j.trre.2010.12.002

Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas

Pinazo, Maria-Jesus; Miranda, Blanca; Rodriguez-Villar, Camino; Altclas, Javier; Brunet Serra, Merce; Canas Garcia-Otero, Elias; de Almeida, Eros Antonio; de la Mata Garcia, Manuel; Gascon, Joaquim; Garcia Rodriguez, Magdalena; Manito, Nicolas; Moreno Camacho, Asuncion; Oppenheimer, Federico; Puente Puente, Sabino; Riarte, Adelina; Salas Coronas, Joaquin; Salavert Lleti, Miguel; Sanz, Guillermo F.; Torrico, Faustino; Torrus Tendero, Diego; Ussetti, Piedad; Shikanai-Yasuda, Maria Aparecida

2011

doi: 10.1111/j.1600-0609.2011.01660.x

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

Porter, John B.; Lin, Kai-Hsin; Beris, Photis; Forni, Gian Luca; Taher, Ali; Habr, Dany; Domokos, Gabor; Roubert, Bernard; Thein, Swee Lay

2011

doi: 10.1038/leu.2010.219

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT

Robin, M.; Sanz, G. F.; Ionescu, I.; Rio, B.; Sirvent, A.; Renaud, M.; Carreras, E.; Milpied, N.; Mohty, M.; Beguin, Y.; Bordigoni, P.; de Witte, T.; Picardi, A.; Purtill, D.; Gluckman, E.; Kroger, N.; Rocha, V.

2010

doi: 10.3324/haematol.2009.017608

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: Long-term follow-up from two prospective multicenter trials

Piñana JL, Martino R, Gayoso J, Sureda A, de la Serna J, Díez-Martín JL, Vazquez L, Arranz R, Tomás JF, Sampol A, Solano C, Delgado J, Sierra J, Caballero D

2010

doi: 10.1007/s00277-010-0997-y

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR

2010

doi: 10.1007/s10549-009-0680-y

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Esteban Cardeñosa E, Bolufer Gilabert P, de Juan Jimenez I, Palanca Suela S, Barragán González E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E

2010

doi: 10.1016/j.jacc.2009.08.092

Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction

Armiñán A, Gandía C, García-Verdugo JM, Lledó E, Trigueros C, Ruiz-Saurí A, Miñana MD, Solves P, Payá R, Montero JA, Sepúlveda P

2020

doi: PMID: 19944434

Paroxismal Nocturnal Hemoglobinuria: New Treatments and General Guidelines for Diagnosis

Morado M, Subirá D, López Rubio M; Grupo Español para el Estudio de Hemoglobinuria Paroxística Nocturna por Citometría de Flujo (Marta Morado, Dolores Subiŕa, José M Bosch, María Angeles Cuadrado, Angelina Lemes, Amparo Sempere, María Belén Vidriales, Montserrat López Rubio ) Hemoglobinuria paroxística nocturna: nuevos tratamientos y recomendaciones generales para su diagnóstico

2010

doi: 10.1016/j.medcli.2009.10.036

Profilaxis antifúngica en pacientes oncohematológicos: revisión de la bibliografía médica y recomendaciones

Cámara R de L, Mensa J, Carreras E, Cuenca-Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA

2010

doi: 10.1038/bmt.2009.362

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings

Piñana JL, Valcárcel D, Fernández-Avilés F, Martino R, Rovira M, Barba P, Martínez C, Brunet S, Sureda A, Carreras E, Sierra J

2010

doi: 10.1007/s10549-009-0316-2

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

Palanca Suela S, Esteban Cardeñosa E, Barragán González E, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Montalar Salcedo J, Castel Sánchez V, Bolufer Gilabert P

2010

doi: 10.1016/j.leukres.2010.03.009

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

Gattermann, N., Finelli, C., Della Porta, M., Fenaux, P., Ganser, A., Guerci-Bresler, A., ..., Zweegman, S.

2010

Long-term management of chronic immune thrombocytopenic purpura in adults

Palau J, Jarque I, Sanz MA

2010

DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

Alvarez S, Suela J, Valencia A, Fernández A, Wunderlich M, Agirre X, Prosper F, Martín-Subero JI, Maiques A, Acquadro F, Rodriguez Perales S, Calasanz MJ, Román-Gómez J, Siebert R, Mulloy JC, Cervera J, Sanz MA, Esteller M, Cigudosa JC

2010

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia

Sanz J, Sanz MA, Saavedra S, Lorenzo I, Montesinos P, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, la Rubia de J, Moscardó F, Romero M, Luna I, Montava A, Cañabate S, Sanz GF

2010

International consensus report on the investigation and management of primary immune thrombocytopenia

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ

2010

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD, European LeukemiaNet

2010

Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia

Martín V, Valencia A, Agirre X, Cervera J, San Jose-Eneriz E, Vilas-Zornoza A, Rodriguez-Otero P, Sanz MA, Herrera C, Torres A, Prosper F, Román-Gómez J

2010

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, Recher C, Thomas X, Rayon C, Castaigne S, Tournilhac O, de Botton S, Ifrah N, Cahn J-Y, Solary E, Gardin C, Fegeux N, Bordessoule D, Ferrant A, Meyer-Monard S, Vey N, Dombret H, Degos L, Chevret S, Fenaux P, for the European APL Group

2010

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, Luño E, Sánchez J, Vellenga E, Rayón C, Milone G, la Serna de J, Rivas C, González JD, Tormo M, Amutio E, González M, Brunet S, Löwenberg B, Sanz MA

2010

A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia

Valencia A, Cervera J, Such E, Ibáñez M, Barragán E, Fuster Ó, Bolufer P, Moscardó F, Sanz MA

2010

Open issues on bleeding and thrombosis in acute promyelocytic leukemia

Sanz MA, Montesinos P

2010

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT

la Cámara de R, Jarque I, Sanz MA, Grau S, Casado MA, Sabater FJ, Carreras E

2010

Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci

Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, Bernasconi P, Di Raimondo F, Stanghellini MTL, Marco P, Mays AN, Döhner H, Sanz MA, Amadori S, Grimwade D, Lo-Coco F

2010

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Sanz MA, Montesinos P, Rayón C, Holowiecka A, la Serna de J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Löwenberg B, PETHEMA and HOVON Groups

2010

Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source

Ferrá C, Sanz J, la Cámara de R, Sanz G, Bermúdez A, Valcarcel D, Rovira M, Serrano D, Caballero D, Espigado L, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Josep-Maria Ribera, on behalf of GETH Grupo Español de Trasplante Hematopoyético and PETHEMA Programa Español de Tratamiento en Hematología SSOH

2010

Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia

Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, la Rubia de J, Moscardó F, Martinez D, Gómez I, López M, Sanz MA, Sanz GF

2010

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy

Montesinos P, González JD, Gonzalez J, Rayon C, de Lisa E, Amigo ML, Ossenkoppele GJ, Penarrubia MJ, Perez-Encinas M, Bergua J, Debén G, Sayas MJ, La Serna de J, Ribera JM, Bueno J, Milone G, Rivas C, Brunet S, Löwenberg B, Sanz M

2010

High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA

Aljurf M, Qurashi Al F, Mohareb Al F, Sahovic E, Sharif Al F, Zahrani Al H, Shanqeeti Al A, Owaidah T, Iqbal A, Zaidi SZA, Nurgat ZA, Sanz M, Chaudhri N

2010

Risk-adapted treatment for low- and intermediate-risk acute promyelocytic leukemia

Sanz MA, Montesinos P

2010

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

la Rubia de J, Roig M, Ibáñez A, García I, Vera JA, Aguilar C, del Campo R, González N, Martínez R, Palomera L, Picón I, Rodríguez JN, Sanz MA

2010

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study

la Rubia de J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Del Río-Garma J, Sanz MA, Grupo Español de Aféresis

2010

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Tallman MS, Kim HT, Montesinos P, Appelbaum FR, la Serna de J, Bennett JM, Debén G, Bloomfield CD, González J, Feusner JH, González M, Gallagher R, González-San Miguel JD, Larson RA, Milone G, Paietta E, Rayón C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MA

2010

doi: 10.1200/JCO.2009.23.8329

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

Fenaux, Pierre; Mufti, Ghulam J.; Hellstrom-Lindberg, Eva; Santini, Valeria; Gattermann, Norbert; Germing, Ulrich; Sanz, Guillermo; List, Alan F.; Gore, Steven; Seymour, John F.; Dombret, Herve; Backstrom, Jay; Zimmerman, Linda; McKenzie, David; Beach, C. L.; Silverman, Lewis R.

2010

doi: 10.1016/S1470-2045(10)70127-3

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

Eapen, Mary; Rocha, Vanderson; Sanz, Guillermo; Scaradavou, Andromachi; Zhang, Mei-Jie; Arcese, William; Sirvent, Anne; Champlin, Richard E.; Chao, Nelson; Gee, Adrian P.; Isola, Luis; Laughlin, Mary J.; Marks, David I.; Nabhan, Samir; Ruggeri, Annalisa; Soiffer, Robert; Horowitz, Mary M.; Gluckman, Eliane; Wagner, John E.

2010

doi: https://www.ncbi.nlm.nih.gov/pubmed/20683042

Influence on Busilvex (R) Pharmacokinetics of Clonazepam Compared to Previous Phenytoin Historical Data

Carreras, E.; Cahn, J. Y.; Puozzo, C.; Kroeger, N.; Sanz, G.; Buzyn, A.; Bacigalupo, A.; Vernant, J. P.

2010

doi: 10.1007/s00277-009-0794-7

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements

Remacha, Angel F.; Arrizabalaga, Beatriz; Del Canizo, Consuelo; Sanz, Guillermo; Villegas, Ana

2010

doi: 10.1016/j.leukres.2010.05.021

Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion

Fenaux, Pierre; Bowen, David; Gattermann, Norbert; Hellstrom-Lindberg, Eva; Hofmann, Wolf-Karsten; Pfeilstoecker, Michael; Sanz, Guillermo; Santini, Valeria

2010

doi: 10.1016/j.beha.2010.05.001

Umbilical cord blood transplantation from unrelated donors in adult patients with chronic myeloid leukaemia

Sanz, Jaime; Sanz, Guillermo F.

2009

doi: 10.1038/bmt.2009.78

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

R Martino, J L Piñana, R Parody, D Valcarcel, A Sureda, S Brunet, J Briones, J Delgado, F Sánchez, N Rabella, J Sierra

2009

doi: 10.1080/14653240802582109

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen

Delgado J, Marco A, Moreno E, Piñana JL, Valcarcel D, Martino R, Briones J, Sureda A, Brunet S, Sierra J

2009

doi: 10.1016/j.bbmt.2009.07.013

Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J

2009

doi: 10.1007/s10561-009-9133-4

Microbiological analysis of cryopreserved human heart valves after storage: A survey of 3 banks in Spain

Villalba R, Mirabet V, Rendal E, González AI, Solves P, Andión C, Gómez Villagrán JL.

2009

doi: 10.1159/000232382

Characteristics of Umbilical Cord Blood Units Collected from Preterm Deliveries

Solves P, López M, Mirabet V, Blanquer A, Roig R, Perales A

2009

doi: 10.1111/j.1537-2995.2009.02146.x

Chagas disease screening in cord blood donors

Solves P, Parada C, Roig R, Hernández MC, Rodríguez R, Prat I

2009

doi: 10.1016/j.bbmt.2008.10.011

Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience

Piñana JL, Valcárcel D, Martino R, Barba P, Moreno E, Sureda A, Vega M, Delgado J, Briones J, Brunet S, Sierra J

2009

doi: 10.3233/CH-2009-1156

Erythrocyte aggregability and AB0 blood groups.

Vayá A, Martínez Triguero M, Ricart A, Plumé G, Solves P, Corella D, Romagnoli M

2009

doi: 10.3109/14653240903253865

A new automatic device for routine cord blood banking: Critical analysis of different volume reduction methodologies

Solves P, Mirabet V, Blanquer A, Delgado-Rosas F, Planelles D, Andrade M, Carbonell-Uberos F, Soler MA, Roig R

2009

Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia

Valencia A, Cervera J, Such E, Barragán E, Bolufer P, Fuster Ó, Collado R, Martínez J, Sanz MA

2009

[Pocket guide to invasive mycoses in onco-hematologic patients]

Bermúdez A, Carreras E, la Cámara de R, Eraso E, Fortún J, García-Ruiz JC, Guarro J, Jarque I, Marcos de Lucas E, Mayayo E, Pastor FJ, Pemán J, Pontón J, Quindós G, Salavert-Lleti M, Sanz MA, Zaragoza R

2009

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, la Serna de J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Löwenberg B, Sanz MA

2009

Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial

Blanes M, la Rubia de J, Lahuerta JJ, González JD, Ribas P, Solano C, Alegre A, Sanz MA

2009

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Sanz MA, Grimwade D, Tallman MS, Löwenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F

2009

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN

2009

[Micafungin in invasive candidiasis among oncohematological patients]

Jarque I, Sanz MA

2009

Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study

la Rubia de J, Montesinos P, Martino R, Jarque I, Rovira M, Vazquez L, López J, Batlle M, la Cámara de R, Juliá A, Lahuerta JJ, Debén G, Díaz J, García R, Sanz MA

2009

doi: DOI: 10.1016/j.medcli.2009.01.008

Treatment of fungal infections in patients with hematologic neoplasia

Mensa J, la Cámara de R, Carreras E, Cuenca-Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA

2009

Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience

Kelaidi C, Chevret S, de Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Ades L

2009

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation

Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert-Lleti M, Córdoba J, Gómez L, Weiss S, Moscardó F, la Rubia de J, Larrea L, Sanz MA, Sanz GF

2009

Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies

Moscardó F, Sanz J, Senent L, Cantero S, la Rubia de J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF

2009

Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis

Fuster Ó, Barragán E, Bolufer P, Cervera J, Larráyoz MJ, Jiménez-Velasco A, Martínez-López J, Valencia A, Moscardó F, Sanz MA

2009

Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML)

Such E, Cervera J, Valencia A, Garcia-Casado Z, Senent ML, Sanz MA, Sanz GF

2009

Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia

Valencia A, Román-Gómez J, Cervera J, Such E, Barragán E, Bolufer P, Moscardó F, Sanz GF, Sanz MA

2009

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

Montesinos P, Díaz-Mediavilla J, Debén G, Prates V, Tormo M, Rubio V, Pérez I, Fernández I, Viguria M, Rayón C, González J, la Serna de J, Esteve J, Bergua JM, Rivas C, González M, González JD, Negri S, Brunet S, Löwenberg B, Sanz MA

2009

FLT3 inhibition as a targeted therapy for acute myeloid leukemia

Sanz M, Burnett A, Lo-Coco F, Löwenberg B

2009

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

Pascual AM, Téllez N, Boscá I, Mallada J, Belenguer A, Abellán I, Sempere AP, Fernández P, Magraner MJ, Coret F, Sanz MA, Montalbán X, Casanova B

2009

doi: 10.1200/JCO.2007.15.8865

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Rodrigues, Celso A.; Sanz, Guillermo; Brunstein, Claudio G.; Sanz, Jaime; Wagner, John E.; Renaud, Marc; de Lima, Marcos; Cairo, Mitchell S.; Fuerst, Sabine; Rio, Bernard; Dalley, Christopher; Carreras, Enric; Harousseau, Jean-Luc; Mohty, Mohamad; Taveira, Denis; Dreger, Peter; Sureda, Anna; Gluckman, Eliane; Rocha, Vanderson

2009

doi: 10.1016/S1470-2045(09)70003-8

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Fenaux, Pierre; Mufti, Ghulam J.; Hellstrom-Lindberg, Eva; Santini, Valeria; Finelli, Carlo; Giagounidis, Aristoteles; Schoch, Robert; Gattermann, Norbert; Sanz, Guillermo; List, Alan; Gore, Steven D.; Seymour, John F.; Bennett, John M.; Byrd, John; Backstrom, Jay; Zimmerman, Linda; McKenzie, David; Beach, C. L.; Silverman, Lewis R.

2009

doi: 10.1111/j.1399-0039.2009.01378.x

HLA-B*0777 allele differs from B*0707 by a single residue in the antigen binding groove

Balas, A.; Planelles, D.; Sanz, G. F.; Montoro, J. A.; Vicario, J. L.

2009

doi: 10.1038/leu.2008.365

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

Willemze, R.; Rodrigues, C. A.; Labopin, M.; Sanz, G.; Michel, G.; Socie, G.; Rio, B.; Sirvent, A.; Renaud, M.; Madero, L.; Mohty, M.; Ferra, C.; Garnier, F.; Loiseau, P.; Garcia, J.; Lecchi, L.; Koegler, G.; Beguin, Y.; Navarrete, C.; Devos, T.; Ionescu, I.; Boudjedir, K.; Herr, A-L; Gluckman, E.; Rocha, V.

2008

doi: 10.1111/j.1399-3062.2008.00331.x

Donor screening for hepatitis B virus infection in a cell and tissue bank

Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ

2008

doi: 10.1007/s10549-007-9818-y

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain

Esteban Cardeñosa E, Bolufer Gilabert P, Palanca Suela S, Oltra Soler S, Barragán González E, Velasco Sampedro E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E

2008

doi: 10.1007/s10549-007-9839-6

Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family

Palanca Suela S, Esteban Cardeñosa E, Barragán González E, Oltra Soler S, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Bolufer Gilabert P

2008

doi: 10.1182/blood-2008-05-159632

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid andanthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by thePETHEMA Group

Sanz MA1, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, Bergua JM, León A, Negri S, González M, Rivas C, Esteve J, Milone G, González JD, Amutio E, Brunet S, García-Laraña J, Colomer D, Calasanz MJ, Chillón C, Barragán E, Bolufer P, Lowenberg B.

2008

doi: 10.1016/j.cryobiol.2008.07.008

Long-term storage in liquid nitrogen does not affect cell viability in cardiac valve allografts

Mirabet V, Carda C, Solves P, Novella-Maestre E, Carbonell-Uberos F, Caffarena JM, Hornero F, Montero JA, Roig RJ

2008

doi: 10.1016/j.cca.2008.05.021

Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1):Comparison with WT1 gene expression

Barragán E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardó F, Senent L, Such E, Sanz MA, Bolufer P

2008

doi: 10.3324/haematol.12880

Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, Hernández-Boluda JC, Remigia MJ, Jarque I, Calabuig ML, Garcia-Noblejas A, Alberola J, Tamarit A, Gimeno C, Navarro D

2008

doi: 10.1016/j.healun.2008.03.006

Heart Transplantation in a Patient With Systemic Mastocytosis

Moro JA, Almenar L, Jarque I, Martinez-Dolz L, Hernández MD, Crespo M, Salvador A

2008

2008

doi: 10.1200/JCO.2007.11.1641

Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J

2008

doi: 10.1016/j.diagmicrobio.2007.07.014

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Pemán J, Bosch M, Cantón E, Viudes A, Jarque I, Gómez-García M, García-Martínez JM, Gobernado M

2008

Intensive chemotherapy and stem cell transplantation in myelodysplastic syndromes

Sanz, G.F., de Witte, T.

2008

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J, Jarque I, Sanz G, Sanz MA

2008

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Ades L,? Sanz MA,2 Chevret S, Montesinos P, Chevallier P, Raffoux E, Vellenga E, Guerci A, Pigneux A, Huguet F, Rayon C, Stoppa AM, de la Serna J, Cahn JY, Meyer-Monard S, Pabst T, Thomas X, de Botton S, Parody R, Verruga J, Lamy T, Vekhoff A, Negri S, Ifrah N, Dombret H, Ferrant A, Bron D, Degos L, Fenaux P

2008

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JThM, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL

2008

Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

Sanz MA, de la Cámara R, Jarque I, López J, Madero L, Ruiz I, Vázquez L, Vallejo C

2008

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

de la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, Esteve J, Bergua JM, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA

2008

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the pediatric-based protocol PETHEMA ALL-96

Ribera JM, Oriol A, Sanz MA, Tormo M, Fernandez-Abellan P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ

2008

Follow-up of healthy donors receiving G-CSF for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry

De la Rubia J, De Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martínez D, Paniagua C, Díaz MA, Sanz MA

2008

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

Cilloni D, Messa F, Arruga F, Defilippi Ll, Gottardi E, Fava M, Carturan S, Catalano R, Bracco E, Messa E, Nicoli P, Diverio D, Sanz MA, Martinelli G, Lo-Coco F, Saglio G

2008

Acute promyelocytic leukemia: Recent advances in diagnosis and management

Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA

2008

Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q- syndrome

Valencia A, Cervera J, Such E, Sanz MA, Sanz GF

2008

Four new cases of therapy-related acute promyelocytic leukemia after Mitoxantrone

Bosca I, Pascual AM, Casanova B, Coret F, Sanz MA

2008

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

Hasan SK, Mays AN, Ottone T, Ledda A, La Nasa G, Cattaneo Ch, Borlenghi E, Melillo L, Montefusco E, Cervera J, Stephen C, Satchi G, Lennard A, Libura M, Byl JA, Osheroff N, Amadori S, Felix CA, Voso MT, Sperr WR, Esteve J, Sanz MA, Grimwade D, Lo-Coco F

2008

Guía clínica para el tratamiento de las infecciones causadas por Estafilococo Aureus meticilin-resistente

Mensa J, Barberán J, Llinares P, Picazo J, Bouza E, Alvarez-Lerma F, Borges M, Serrano R, León C, Guirao X, Arias J, Carreras E, Sanz M, García-Rodríguez J

2008

Momento actual de las trombopoyetinas

Romero M, Jarque I, Palau J, Sanz MA

2008

doi: 10.1111/j.1537-2995.2008.01753.x

A broken cord blood bag: placing the unit in a sterile zip-lock bag before thawing prevents catastrophic events

Larrea, Luis; Sanz, Guillermo; Solves, Pilar; Mirabet, Vicente; Roig, Roberto

2008

doi: 10.3332/ecancer.2008.118

The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.

Silverman, L R; Fenaux, P; Mufti, G J; Santini, V; Hellstrom-Lindberg, E; Gattermann, N; Sanz, G; List, A F; Gore, S D; Seymour, J F; Backstrom, J; McKenzie, D; Beach, C L

2008

doi: 10.3332/ecancer.2008.121

Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.

Fenaux, P; Mufti, G J; Hellstrom-Lindberg, E; Santini, V; Gattermann, N; Sanz, G; List, A F; Gore, S D; Seymour, J F; Backstrom, J; Zimmerman, L; McKenzie, D; Beach, C L; Silverman, L B

2008

doi: 10.3324/haematol.13012

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-

Mallo, Mar; Arenillas, Leonor; Espinet, Blanca; Salido, Marta; Maria Hernandez, Jesus; Lumbreras, Eva; del Rey, Monica; Arranz, Eva; Ramiro, Soraya; Font, Patricia; Gonzalez, Olga; Renedo, Monica; Cervera, Jose; Such, Esperanza; Sanz, Guillermo F.; Luno, Elisa; Sanzo, Carmen; Gonzalez, Miriam; Jose Calasanz, Maria; Mayans, Jose; Garcia-Ballesteros, Carlos; Amigo, Victoria; Collado, Rosa; Oliver, Isabel; Carbonell, Felix; Bureo, Encarna; Insunza, Andres; Yanez, Lucrecia; Jose Muruzabal, Maria; Gomez-Beltran, Elena; Andreu, Rafael; Leon, Pilar; Gomez, Valle; Sanz, Angeles; Casasola, Natalia; Moreno, Esperanza; Alegre, Adrian; Luisa Martin, Maria; Pedro, Carmen; Serrano, Sergi; Florensa, Lourdes; Sole, Francesc

2008

doi: 10.1007/s00277-008-0449-0

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

Giagounidis, Aristoteles; Fenaux, Pierre; Mufti, Ghulam J.; Muus, Petra; Platzbecker, Uwe; Sanz, Guillermo; Cripe, Larry; Von Lilienfeld-Toal, Marie; Wells, Richard A.

2008

doi: 10.3324/haematol.11575

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Montesinos, Pau; Lorenzo, Ignacio; Martin, Guillermo; Sanz, Jaime; Perez-Sirvent, Maria Luz; Martinez, David; Orti, Guillermo; Algarra, Lorenzo; Martinez, Jesus; Moscardo, Federico; de la Rubia, Javier; Jarque, Isidro; Sanz, Guillermo; Sanz, Miguel A.

2008

doi: 10.3324/haematol.13405

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Mufti, Ghulam J.; Bennett, John M.; Goasguen, Jean; Bain, Barbara J.; Baumann, Irith; Brunning, Richard; Cazzola, Mario; Fenaux, Pierre; Germing, Ulrich; Hellstrom-Lindberg, Eva; Jinnai, Itsuro; Manabe, Atsushi; Matsuda, Akira; Niemeyer, Charlotte M.; Sanz, Guillermo; Tomonaga, Masao; Vallespi, Teresa; Yoshimi, Ayami

2008

doi: 10.1002/cncr.23697

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

Kantarjian, Hagop; O'Brien, Susan; Ravandi, Farhad; Cortes, Jorge; Shan, Jianqin; Bennett, John M.; List, Alan; Fenaux, Pierre; Sanz, Guillermo; Issa, Jean-Pierre; Freireich, Emil J.; Garcia-Manero, Guillermo

2007

doi: 10.1111/j.1600-6143.2007.01964.x

Bloodstream infections among transplant recipients: Results of a nationwide surveillance in Spain

Moreno A, Cervera C, Gavaldá J, Rovira M, de la Cámara R, Jarque I, Montejo M, de la Torre-Cisneros J, Miguel Cisneros J, Fortún J, López-Medrano F, Gurguí M, Muñoz P, Ramos A, Carratalá J

2007

doi: 10.1532/IJH97.E0704

Results of Compassionate Therapy with Intrathecal Depot Liposomal Cytarabine in Acute Myeloid Leukemia Meningeosis

Sancho JM, Deben G, Parker A, Piñana JL, Bolam S, Sánchez-García E, Giménez E, Pascual T, Fernández-Abellán P, Palomera L, Ribera JM